GregoryAGrabowskiMD
Medical Genetics • Cincinnati, OHClinical Biochemical Genetics, Clinical Genetics, Clinical Molecular Genetics
Professor, Pediatrics, University of Cincinnati College of Medicine
Dr. Grabowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
Ml 4006
Cincinnati, OH 45229Phone+1 513-636-4760Fax+1 513-636-7297
Summary
- Dr. Grabowski received his M.D. from the University of Minnesota where he also completed his residency in Pediatrics and fellowship training in Human Genetics. He then established his research and clinical programs at the Mount Sinai School of Medicin where he developed the world’s largest clinic for patients afflicted with Gaucher disease and other lysosomal diseases. He established basic research and diagnostic laboratories for genetic diseases as well as the first treatment center for enzyme therapy in Gaucher disease. Following these highly productive 13.5 years, he became the A. Graeme Mitchell Chair of Human Genetics, and Director of Human Genetics (DHG) at the Cincinnati Children’s Hospital Research Foundation. He was Professor of Molecular Genetics and Biochemistry, and Pediatrics, at the University of Cincinnati College of Medicine. In these positions, he formed the clinical, educational, diagnostic, and research infrastructure for the DHG and its ~30 faculty. During his research career, he has published over 320 scholarly works on the basic and clinical sciences of lysosomal storage and genetic diseases, while maintaining active clinical and treatment programs genetic diseases. He has continuously served on committees of the National Institutes of Health, the national and state governments, and many philanthropic (through the Project Hope Gaucher Disease Initiative) and patient foundations. He is a member of the American Society for Clinical Investigation, the American Association of Physicians, the editorial board of Molecular Genetics and Metabolism, and other societies. He has served as President of the Society for Inherited Metabolic Diseases. His continuing passion has been to discover and develop specific treatments for inherited diseases. In 2014, he joined Synageva BioPharma as Chief Scientific Officer. After Alexion acquired Synageva in June 2015, he became Emeritus Professor of Pediatrics and Genetics and consults for several Biotech companies.
Education & Training
University of Minnesota Medical SchoolPost-Doctoral Fellowship, 1976 - 1979- University of MinnesotaResidency, Pediatrics, 1974 - 1978
- University of Minnesota Medical SchoolClass of 1974
Certifications & Licensure
OH State Medical License 1992 - 2025
SC State Medical License 2011 - 2019
MN State Medical License 1978 - 1979- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1991
Clinical Trials
- Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
- Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up Start of enrollment: 2010 Nov 01
Publications & Presentations
PubMed
- 4 citationsTherapies for lysosomal storage diseases: Principles, practice, and prospects for refinements based on evolving science.Gregory A Grabowski, Pramod K Mistry
Molecular Genetics and Metabolism. 2022-07-30 - 30 citationsGaucher disease: Basic and translational science needs for more complete therapy and management.Gregory A. Grabowski, Armand H. Matheny Antommaria, Edwin H. Kolodny, Pramod K. Mistry
Molecular Genetics and Metabolism. 2021-02-01 - 19 citationsGaucher disease and SARS-CoV-2 infection: Emerging management challenges.Pramod K. Mistry, Manisha Balwani, Deborah Barbouth, T. Andrew Burrow, Edward I. Ginns
Molecular Genetics and Metabolism. 2020-07-01
Press Mentions
Rare Genetic Disorder Provides Unique Insight into Parkinson’s DiseaseJune 23rd, 2011
University of Utah Health Program General Surgery ResidencyJanuary 13th, 2021
Grant Support
- Epidemiology And Natural History Of Wolman And Cholesteryl Ester Stor (GRABOWSKI)National Institute Of Neurological Disorders And Stroke2010–2011
- Studies Of Gaucher Disease: A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Therapy Of Gaucher Disease: In Vivo Enhancement Of Residual Mutant ActivityNational Institute Of Neurological Disorders And Stroke2010
- Therapy Of Neuronopathic Gaucher DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2010
- Therapy Of Gaucher Disease: In Vivo Enhancement Of Residual Mutant ActivityNational Institute Of Neurological Disorders And Stroke2009
- GrabowskiNational Institute Of Neurological Disorders And Stroke2009
- Therapy Of Neuronopathic Gaucher DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2009
- Studies Of Gaucher Disease: A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1993–2009
- Use Of Hammerhead Ribozymes In Murine Models Of OlNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2007
- Gaucher Disease StudyNational Center For Research Resources2004–2007
- Studies Of Prosaposin'S Physiologic RoleNational Institute Of Neurological Disorders And Stroke2003–2007
- Inborn Errors Of Sphingolipid CatabolismNational Institute Of Neurological Disorders And Stroke2000–2004
- Prosaposins Physiologic RoleNational Institute Of Neurological Disorders And Stroke1997–2001
- Enzyme Augmentation Therapy Of Gaucher DiseaseNational Center For Research Resources1995–2001
- Clinical And Molecular Studies Of Gaucher DiseaseNational Center For Research Resources1995–2001
- Gaucher DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000
- Inborn Errors Sphingolipid CatabolismNational Institute Of Neurological Disorders And Stroke1995–1998
- Inborn Errors Of MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1997
- Gaucher Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1995
- Gaucher'S Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- Gaucher Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1992
- Studies Of Gaucher Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1991
- Studies Of Gaucher Disease: A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1990
- Gaucher Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1988
- Gaucher Disease--A Prototype LipidosisNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
